<DOC>
	<DOCNO>NCT00248261</DOCNO>
	<brief_summary>Serotonin re-uptake inhibitor , sertraline , medication choice post-traumatic stress disorder . However , take several week ameliorate symptom . Therefore , add ziprasidone ( vs. placebo ) medication first four week sertraline order find strategy accelerate symptomatic relief .</brief_summary>
	<brief_title>Ziprasidone Sertraline PTSD</brief_title>
	<detailed_description>A current problem pharmacotherapy PTSD medication choice , serotonin re-uptake inhibitor , take several week show considerable effect PTSD symptom . Addition typical neuroleptic , ziprasidone , offer potential strategy bring faster symptomatic relief , display anxiolytic property without risk dependence . Therefore , addition standard sertraline therapy ( least 8 week ) , give ziprasidone vs. placebo first four week double-blind randomized design .</detailed_description>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Clinical diagnosis PostTraumatic Stress Disorder Lifetime psychotic disorder , current substance dependency , gravidity , lactation , tartrazine hypersensitivity , contraindication sertraline ziprasidone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>ziprasidone , sertraline , PTSD</keyword>
</DOC>